Upside and Downside of Tumor Necrosis Factor Blockers for Treatment of Immune/Inflammatory Diseases-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Upside and Downside of Tumor Necrosis Factor Blockers for Treatment of Immune/Inflammatory Diseases

Published:2019 Issue:6 Volume:39 Page:439-479
ISSN:1040-8401
Container-title:Critical Reviews in Immunology
language:en
Short-container-title:Crit Rev Immunol

Author:

Kunnumakkara Ajaikumar,Thakur Krishan Kumar,Rana Varsha,Bora Bidisha,Banik Kishore,Khatoon Elina,Sailo Bethsebie L.,Shabnam Bano,Girisa Sosmitha,Gupta Subhash C.,Aggarwal Bharat B.

Publisher

Begell House

Subject

Immunology,Immunology and Allergy

Link

http://www.dl.begellhouse.com/download/article/5dd4946d31454b26/CRI-33205.pdf

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The anti-inflammatory and tolerogenic potential of small spleen peptides;Frontiers in Immunology;2024-09-02

2. Exploring the Therapeutic Potential of Mesenchymal Stem Cells-derived conditioned medium: An In-depth Analysis of Pain Alleviation, Spinal CCL2 Levels, and Oxidative Stress;Cell Biochemistry and Biophysics;2024-07-20

3. Evaluation of infliximab-induced genotoxicity and possible action on BCL-2 and P53 genes;Journal of Toxicology and Environmental Health, Part A;2024-06-26

4. Anti-tumor immune potentiation targets-engineered nanobiotechnologies: Design principles and applications;Progress in Materials Science;2024-04

5. Photodynamic therapy: a new approach to the treatment of Nontuberculous Mycobacterial skin and soft tissue infections;Photodiagnosis and Photodynamic Therapy;2023-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP